Tag: Automation
Stability Study Software Takes Centre Stage at Stability VI Symposia
Matrix Stability, Autoscribe Informatics’ software solution for managing stability and shelf-life studies is to be demonstrated at the Stability VI Symposia hosted by the...
Biobank Acutelines: Patient Smart Data and Biological Samples Collection in the Emergency Room
When you are on your way to the emergency room with sirens wailing, you feel that things are serious. But how does the doctor...
UK Biocentre Granted ISO 15189:2012 Accreditation for Sample Processing and Storage Services
UK Biocentre has been granted ISO 15189:2012 Accreditation by UKAS for sample processing and storage services. This landmark accreditation further extends UK Biocentre’s capabilities,...
UiT’s Treasury Received Millions to Solve Health Challenges Namely Biobanking Storage Capacity
Through the Norwegian biobank consortium, to ensure the research core facility and solve major challenges in the biobanking domain, UiT has received an award...
Next Generation Automation Lab Achieves Huge Productivity Gains
Eli Lilly and Company and their industry partners, including sample management specialists – Ziath, are speeding the discovery of new medicines through the fully...
MRC The Gambia Chooses Matrix Gemini LIMS to Drive Automation and Efficiency
The Medical Research Council Unit The Gambia (MRCG), a major center for medical research excellence in West Africa, has chosen Matrix Gemini LIMS to...
Cord Blood Registry Upgrading To ThermoGenesis’ Next-Generation AXP® II System
ThermoGenesis, a wholly owned subsidiary of Cesca
Therapeutics and a market leader in automated cellular processing has announced
that CBR® (Cord Blood Registry), the USA's largest...
Memo Therapeutics Takes A Major Step In High-Throughput Functional Antibody Screening
Memo Therapeutics has announced the development of a droplet sorter that enables functional antibody screening in a high-throughput format.
Founded in 2012, located in the...
Cesca Therapeutics’ CTO Talks CAR-T Manufacturing
Cesca Therapeutics Inc. is in the business of developing, commercializing and marketing a range of automated technologies for CAR-T and other cell-based therapies. The...
Cesca Therapeutics Inc. Has Released The X-Mini™ Cell Selection Kit For The CAR-T Research...
Two CAR-T cell therapies have been approved by the USA Food and Drug Administration (FDA) within the past year for blood cancers. Cellular therapies...



















